Viraday Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Viraday Tablet is a fixed-dose combination of efavirenz (a non-nucleoside reverse transcriptase inhibitor) with emtricitabine and tenofovir disoproxil fumarate (nucleos(t)ide reverse transcriptase inhibitors). Its labelling describes it as a complete regimen for the treatment of HIV infection, taken once daily on an empty stomach at the same time each day. It is described as controlling the infection rather than curing or preventing HIV or AIDS.
Product Information
The following description reflects information associated with efavirenz, emtricitabine, and tenofovir disoproxil fumarate and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described as a complete once-daily regimen for the treatment of HIV infection
- Described as stopping the virus from multiplying, which is described as helping the immune system work better
- Described as neither a cure for nor a means of preventing HIV or AIDS, including after accidental exposure
Described Dosage & Administration
- Swallowed whole on an empty stomach; tablets should not be chewed, crushed, or broken
- Taken at about the same time each day, and no dose should be skipped
- The prescriber’s instructions should be followed and the full course completed
Described Side Effects
Commonly described side effects include:
- Nausea, vomiting, diarrhoea, and abdominal pain
- Rash and allergic reaction
- Decreased white blood cell count (neutrophils)
- Headache, dizziness, and difficulty sleeping (insomnia)
- Low or depressed mood and abnormal dreams
- Tiredness (fatigue)
These are described as commonly temporary. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- The medicine is described as causing dizziness, so driving and tasks needing focus should be avoided
- The doctor should be consulted first if the patient is pregnant or breastfeeding, or has any bone, liver, or kidney disease
- A person who is HIV positive is advised not to breastfeed and not to share personal belongings
- Any persistent or severe side effect should be reviewed by a clinician
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it combines efavirenz, emtricitabine, and tenofovir disoproxil fumarate as a complete once-daily regimen for the treatment of HIV infection. It is described as neither a cure nor a means of preventing HIV or AIDS. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as swallowed whole on an empty stomach at about the same time each day, and not chewed, crushed, or broken. No dose should be skipped and the full course should be completed.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.